Buy Sanofi India, target price Rs 6200: Sharekhan by BNP Paribas

Sharekhan by BNP Paribas has buy call on Sanofi India with a target price of Rs 6200. The current market price of Sanofi India is Rs 5750.8.

Sanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13232.93 Crore) operating in Pharmaceuticals sector.

Sanofi India key Products/Revenue Segments include Pharmaceutical Products, Sale of services, Other Operating Revenue, Export Incentives and Scrap for the year ending 31-Dec-2021.


Financials
For the quarter ended 31-12-2022, the company has reported a Standalone Total Income of Rs 691.90 Crore, down -1.62 % from last quarter Total Income of Rs 703.30 Crore and down -1.75 % from last year same quarter Total Income of Rs 704.20 Crore. Company has reported net profit after tax of Rs 130.90 Crore in latest quarter.

The company’s top management includes Mr.Aditya Narayan, Mr.Rajaram Narayanan, Mr.Cherian Mathew, Mr.Vaibhav Karandikar, Mr.Charles Billard, Mr.Marc Antoine Lucchini, Ms.Usha Thorat, Mr.Rahul Bhatnagar. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors. As on 31-12-2022, the company has a total of 2 Crore shares outstanding.

Investment Rationale
The brokerage believe the emphasis on leveraging the digital platform and divestment of the slow-moving business have led to OPM expansion. Furthermore, it expects the company to post a high single-digit PAT CAGR over the next three years.

Promoter/FII Holdings
Promoters held 60.4 per cent stake in the company as of 31-Dec-2022, while FIIs owned 6.99 per cent, DIIs 19.22 per cent.